journal article·2014-05

In vitro and in vivo studies of three dimensional porous composites of biphasic calcium phosphate/poly ɛ-caprolactone: Effect of bio-functionalization for bone tissue engineering

Kyung-A. Kwak, Md. Anirban Jyoti, Ho-Yeon Song

Publisher page

Abstract

Abstract Biphasic calcium phosphate (BCP) and poly ɛ-caprolactone (PCL) each have many applications as tissue repair materials. In this study, a three dimensional (3D) PCL infiltrated BCP scaffold was prepared. This composite was further modified and bio-functionalized for bone tissue engineering by subsequent amination and immobilization technique using silicon (Si) and fibronectin (FN) on the surfaces (BCP/PCL + Si and BCP/PCL + Si + FN). In this study, such 3D porous scaffolds were evaluated for bone formation applicability. In vitro studies by immunocytochemistry showed cell morphology and adherence on these scaffolds. Interconnected networks like appearance of tubulin and vinculin expression were notably higher in BCP/PCL + Si and BCP/PCL + Si + FN scaffold surfaces than BCP/PCL surfaces. The scaffolds were also investigated detailed and quantitatively using micro-CT tomography for the repair of bone defects (4 mm diameter) in rats. Micro-CT tomography showed the BCP/PCL + Si + FN scaffolds were almost replaced by newly grown bone within 12 weeks after surgery, suggesting that they have an especially strong capacity for osteogenesis, mineralization, and biodegradation for bone replacement.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. The design of scaffolds for use in tissue engineering. Part I10.1089/107632701753337645 ↗
2. Porosity of 3D biomaterial scaffolds and osteogenesis10.1016/j.biomaterials.2005.02.002 ↗
3. Biomimetic materials for tissue engineering10.1016/j.addr.2007.08.041 ↗
4. Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells10.1126/science.6623079 ↗
5. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo10.1677/joe.0.1750405 ↗
6. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis10.1359/JBMR.050708 ↗
7. In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice10.1002/jbmr.5650051013 ↗
8. RGD-coated titanium implants stimulate increased bone formation in vivo10.1016/S0142-9612(99)00161-1 ↗
9. Understanding and controlling the bone–implant interface10.1016/S0142-9612(99)00160-X ↗
10. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function10.1016/S0142-9612(99)00181-7 ↗
11. Chapter 13 Principles underlying the role of adsorbed plasma proteins in blood interactions with foreign materials10.1016/1054-8807(93)90054-6 ↗
12. Titanium with different oxides: in vitro studies of protein adsorption and contact activation10.1016/0142-9612(94)90038-8 ↗
13. Fibronectin and laminin enhance gingival cell attachment to dental implant surfaces in vitro
14. Differential gene expression of collagen-binding small leucine-rich proteoglycans and lysyl hydroxylases, during mineralization by MC3T3-E1 cells cultured on titanium implant material10.1111/j.1600-0722.2005.00208.x ↗
15. Gene expression monitoring in osteoblasts on titanium coated with fibronectin-derived peptide10.4012/dmj.27.744 ↗
16. The effect of the surface modification of titanium using a recombinant fragment of fibronectin and vitronectin on cell behavior10.1016/j.biomaterials.2005.01.060 ↗
17. Vascularization and biocompatibility of scaffolds consisting of different calcium phosphate compounds10.1002/jbm.a.31722 ↗
18. Reconstruction of orbital wall defects with calcium phosphate cement: clinical and histological findings in a sheep model10.1016/j.ijom.2006.07.014 ↗
19. A comparative study of calcium phosphate formation on bioceramics in vitro and in vivo10.1016/j.biomaterials.2005.04.028 ↗
20. Past, present and for the future10.1016/j.jeurceramsoc.2007.12.001 ↗
21. Polymer-bioceramic composites for tissue engineering scaffolds10.1007/s10853-008-2552-y ↗
22. Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological study10.1002/jbm.820240309 ↗
23. Bioactivity in in situ hydroxyapatite–polycaprolactone composites10.1002/jbm.a.30774 ↗
24. Biodegradable PCL scaffolds with an interconnected spherical pore network for tissue engineering10.1002/jbm.a.31396 ↗
25. Controlled release of an antibiotic, gentamicin sulphate, from gravity spun polycaprolactone fibers10.1002/jbm.a.31476 ↗
26. Effects of crystalline microstructure on drug release behavior of poly(ɛ-caprolactone) microspheres10.1016/S0168-3659(03)00367-5 ↗
27. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.0.CO;2-7 ↗
28. Aliphatic polyesters. I. The degradation of poly(ɛ-caprolactone) in vivo10.1002/app.1981.070261124 ↗
29. Surface properties and biocompatibility of solvent-cast poly[ɛ-caprolactone] films10.1016/j.biomaterials.2003.12.003 ↗
30. Surface modification of PCL-TCP scaffolds in rabbit calvaria defects: Evaluation of scaffold degradation profile, biomechanical properties and bone healing patterns10.1002/jbm.a.32633 ↗
31. Surface modification of PCL-TCP scaffolds improve interfacial mechanical interlock and enhance early bone formation: An in vitro and in vivo characterization10.1002/jbm.a.32366 ↗
32. Simple surface modification of poly(ɛ-caprolactone) for apatite deposition from simulated body fluid10.1016/j.biomaterials.2004.07.048 ↗
33. Simple surface modification of poly(ɛ-caprolactone) to induce its apatite-forming ability10.1002/jbm.a.30397 ↗
34. Surface modification of polycaprolactone membrane via aminolysis and biomacromolecule immobilization for promoting cytocompatibility of human endothelial cells10.1021/bm020074y ↗
35. Type I collagen immobilized poly(caprolactone) nanofibers: Characterization of surface modification and growth of fibroblasts10.1002/adem.201180035 ↗
36. Plasma Surface modification for immobilization of bone morphogenic protein-2 on polycaprolactone scaffolds10.7567/JJAP.52.11NF01 ↗
37. Osteogenic activities of MC3T3-E1 cells on heparin-immobilized poly(caprolactone) membranes10.1177/0883911511406329 ↗
38. PCL infiltration into a BCP scaffold strut to improve the mechanical strength while retaining other properties10.3740/MRSK.2010.20.6.331 ↗
39. Bio-functionalization of polycaprolactone infiltrated BCP scaffold with silicon and fibronectin enhances osteoblast activity in vitro10.1016/j.apsusc.2013.03.039 ↗
40. Biochemical and morphological changes associated with long bone abnormalities in silicon deficiency10.1093/jn/110.5.1046 ↗
41. Silicon deprivation decreases collagen formation in wounds and bone, and ornithine transaminase enzyme activity in liver10.1385/BTER:89:3:251 ↗
42. Silica coating of silver nanoparticles using a modified Stöber method10.1016/j.jcis.2004.08.184 ↗
43. The effect of mean pore size on cell attachment, proliferation and migration in collagen–glycosaminoglycan scaffolds for bone tissue engineering10.1016/j.biomaterials.2009.09.063 ↗
44. Understanding the effect of mean pore size on cell activity in collagen–glycosaminoglycan scaffolds10.4161/cam.4.3.11747 ↗
45. Cellular and molecular interactions between MC3T3-E1 pre-osteoblasts and nanostructured titanium produced by high-pressure torsion10.1016/j.biomaterials.2007.05.010 ↗
46. Enhancement of fibronectin fibrillogenesis and bone formation by basic fibroblast growth factor via protein kinase C-dependent pathway in rat osteoblasts10.1016/S0026-895X(24)05626-8 ↗
47. Fibronectin regulates calvarial osteoblast differentiation10.1242/jcs.109.6.1369 ↗
48. Differentiation of the human mesenchymal stem cells derived from bone marrow and enhancement of cell attachment by fibronectin10.2334/josnusd.46.207 ↗